Publication: Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We?
| dc.contributor.authors | Kortekaas, Jeroen; Ergonul, Onder; Moormann, Rob J. M. | |
| dc.date.accessioned | 2022-03-12T17:47:48Z | |
| dc.date.accessioned | 2026-01-11T17:26:16Z | |
| dc.date.available | 2022-03-12T17:47:48Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | ARBO-ZOONET is an international network financed by the European Commission's seventh framework program. The major goal of this initiative is capacity building for the control of emerging viral vector-borne zoonotic diseases, with a clear focus on West Nile virus, Rift Valley fever virus, and Crimean-Congo hemorrhagic fever virus. To evaluate the status quo of control measures against these viruses, an ARBO-ZOONET meeting was held in Istanbul, Turkey, from 19 to 20 November 2009. The symposium consisted of three themes: (1) vaccines: new and existing ones; (2) antivirals: existing and new developments; and (3) antivector vaccines. In addition, a satellite workshop was held on epidemiology and diagnosis. The meeting brought together foremost international experts on the subjects from both within and without the ARBO-ZOONET consortium. This report highlights selected results from these presentations and major conclusions that emanated from the discussions held. | |
| dc.identifier.doi | 10.1089/vbz.2010.0040 | |
| dc.identifier.eissn | 1557-7759 | |
| dc.identifier.issn | 1530-3667 | |
| dc.identifier.pubmed | 20854026 | |
| dc.identifier.uri | https://hdl.handle.net/11424/229836 | |
| dc.identifier.wos | WOS:000282005800012 | |
| dc.language.iso | eng | |
| dc.publisher | MARY ANN LIEBERT, INC | |
| dc.relation.ispartof | VECTOR-BORNE AND ZOONOTIC DISEASES | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | antiviral | |
| dc.subject | ARBO-ZOONET | |
| dc.subject | Crimean-Congo hemorrhagic fever virus | |
| dc.subject | Rift Valley fever virus | |
| dc.subject | Vaccine | |
| dc.subject | Vector | |
| dc.subject | West Nile virus | |
| dc.subject | RECOMBINANT VACCINE | |
| dc.subject | IMMUNE-RESPONSES | |
| dc.subject | NEUTRALIZING ANTIBODIES | |
| dc.subject | ORAL RIBAVIRIN | |
| dc.subject | SAUDI-ARABIA | |
| dc.subject | NSS PROTEIN | |
| dc.subject | EFFICACY | |
| dc.subject | RNA | |
| dc.subject | REPLICATION | |
| dc.subject | RESCUE | |
| dc.title | Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We? | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 718 | |
| oaire.citation.issue | 7 | |
| oaire.citation.startPage | 709 | |
| oaire.citation.title | VECTOR-BORNE AND ZOONOTIC DISEASES | |
| oaire.citation.volume | 10 |
